Clinical Trial Update: Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 safety and tolerability trial in chronic obstructive pulmonary disease has completed, with GlaxoSmithKline listed as the sponsor. The snippet provides…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED